Evidence map›Paper›PMID 41596111›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Unveiling Resveratrone: A High-Performance Antioxidant Substance.

Eunhak Lim, Kyung-Eun Gil, Kyoung-Chan Park

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives.Apoptosis : an international journal on programmed cell death · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eunhak LimDepartment of Chemistry, College of Natural Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Kyung-Eun GilDepartment of Chemistry, College of Natural Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Kyoung-Chan ParkCollege of Medicine, Seoul National University Bundang Hospital, Seoul National University, Seongnam 13620, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrone is a novel compound that was inadvertently discovered by photo-conversion of natural compound resveratrol. Although resveratrol, a representative antioxidant and anti-aging compound, is widely used to promote human health, the benefits of resveratrone have been little studied and remain largely unknown. Since resveratrone has a completely different molecular structure from resveratrol, it has a high possibility of possessing different effects to resveratrol. In this study, the various effects of resveratrone on skin health were revealed, including outstanding antioxidants, whitening, anti-wrinkle, skin regeneration, anti-acne, and so on. Moreover, resveratrone has been confirmed to be an excellent ingredient for skin health because it shows higher performance than resveratrol in most areas.

Indexed as

antibacterialantioxidantascorbic acidcollagenproliferationresveratrolresveratronewhitening

Identifiers

PMID41596111
PMCPMC12838096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.